We are live on ! Find out more
TLSA icon

Tiziana Life Sciences

5 hedge funds and large institutions have $4.18M invested in Tiziana Life Sciences in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

25% more funds holding

Funds holding: 45 (+1)

0.07% more ownership

Funds ownership: 2.2%2.27% (+0.07%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

10% less capital invested

Capital invested by funds: $4.64M → $4.18M (-$461K)

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HighTower Advisors
1
HighTower Advisors
Illinois
$3.63M -$9.31K -6,748 -0.2%
HAG
2
HighPoint Advisor Group
Illinois
$510K +$85.7K +62,085 +120%
Wells Fargo
3
Wells Fargo
California
$41K +$46.3K +33,572 New
Deutsche Bank
4
Deutsche Bank
Germany
$2K +$2.88K +2,089 New
TRCT
5
Tower Research Capital (TRC)
New York
-$1K -400 Closed

TLSA Hedge Fund Activity: Q3 2019 in Review

5 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q3 2019, worth a combined $4.18M — down 9.9% from $4.64M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new TLSA positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was HighPoint Advisor Group, adding an estimated $85.7K. The largest seller was HighTower Advisors, cutting an estimated $9.31K.

  • 5 institutional investors held Tiziana Life Sciences (TLSA) as of Q3 2019, up from 4 in Q2 2019.
  • Funds reported $4.18M of Tiziana Life Sciences stock for Q3 2019, down 9.9% quarter-over-quarter.
  • 2 funds opened new Tiziana Life Sciences positions in Q3 2019 and 1 closed out, a net change of +1 holder.
  • The largest Tiziana Life Sciences buyer in Q3 2019 was HighPoint Advisor Group, an estimated $85.7K added.
  • The largest Tiziana Life Sciences seller in Q3 2019 was HighTower Advisors, an estimated $9.31K sold.

Based on aggregated 13F filings for Q3 2019.